AMP-KINASE AGONISTS OR ADENOSINE PRO-DRUGS AS IMMUNO-STIMULATING AGENTS
The present invention relates to the use of AMP-activated protein kinase (AMP-kinase) agonists or adenosine pro-drugs as immune enhancing compounds, as adjuvants in a vaccine or as anti-inflammatory compounds. The invention further relates to a compositions, vaccines and products comprising an immun...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
28.10.2004
|
| Edition | 7 |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to the use of AMP-activated protein kinase (AMP-kinase) agonists or adenosine pro-drugs as immune enhancing compounds, as adjuvants in a vaccine or as anti-inflammatory compounds. The invention further relates to a compositions, vaccines and products comprising an immune response eliciting molecule and an immune response enhancing compound, wherein said immune enhancing compound is chosen from the group of AMP-activated protein kinase (AMP-kinase) agonists or adenosine pro-drugs.
L'invention concerne l'utilisation d'agonistes de protéine kinase activée par AMP (kinase AMP) ou de promédicaments d'adénosine en tant que composés stimulants les réponses immunitaires, en tant qu'adjuvants dans un vaccin ou en tant que composés anti-inflammatoires. Cette invention concerne également des compositions, vaccins et produits comprenant une molécule provoquant une réponse immunitaire et un composé stimulant une réponse immunitaire, ce composé stimulant une réponse immunitaire étant choisi dans le groupe comprenant des agonistes de protéine kinase activée par AMP (kinase AMP) ou des promédicaments d'adénosine. |
|---|---|
| AbstractList | The present invention relates to the use of AMP-activated protein kinase (AMP-kinase) agonists or adenosine pro-drugs as immune enhancing compounds, as adjuvants in a vaccine or as anti-inflammatory compounds. The invention further relates to a compositions, vaccines and products comprising an immune response eliciting molecule and an immune response enhancing compound, wherein said immune enhancing compound is chosen from the group of AMP-activated protein kinase (AMP-kinase) agonists or adenosine pro-drugs.
L'invention concerne l'utilisation d'agonistes de protéine kinase activée par AMP (kinase AMP) ou de promédicaments d'adénosine en tant que composés stimulants les réponses immunitaires, en tant qu'adjuvants dans un vaccin ou en tant que composés anti-inflammatoires. Cette invention concerne également des compositions, vaccins et produits comprenant une molécule provoquant une réponse immunitaire et un composé stimulant une réponse immunitaire, ce composé stimulant une réponse immunitaire étant choisi dans le groupe comprenant des agonistes de protéine kinase activée par AMP (kinase AMP) ou des promédicaments d'adénosine. |
| Author | LEO, OBERDAN BAUS, ERIKA |
| Author_xml | – fullname: BAUS, ERIKA – fullname: LEO, OBERDAN |
| BookMark | eNqNy78KwjAQgPEMOvjvHc4HCFQydD5sjEFzV3oJHUuROElaqO-PDj6A07f8vq1alankjXIYWn3zhGIBHZOXKMAdYGOJxZOFtmPddMkJoIAPIRFriT6kO0ZP7ntZirJX6-f4WvLh1506Xmw8X3WepyEv8_jIJb-HnitTmdrUJzTmH_MBDIsunQ |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | AGONISTES DE KINASE AMP OU PROMEDICAMENTS D'ADENOSINE EN TANT QU'AGENTS IMMUNOSTIMULANTS |
| Edition | 7 |
| ExternalDocumentID | WO03037371A3 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_WO03037371A33 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 15:26:20 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_WO03037371A33 |
| Notes | Application Number: WO2002EP12102 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20041028&DB=EPODOC&CC=WO&NR=03037371A3 |
| ParticipantIDs | epo_espacenet_WO03037371A3 |
| PublicationCentury | 2000 |
| PublicationDate | 20041028 |
| PublicationDateYYYYMMDD | 2004-10-28 |
| PublicationDate_xml | – month: 10 year: 2004 text: 20041028 day: 28 |
| PublicationDecade | 2000 |
| PublicationYear | 2004 |
| RelatedCompanies | UNIVERSITE LIBRE DE BRUXELLES LEO, OBERDAN BAUS, ERIKA |
| RelatedCompanies_xml | – name: BAUS, ERIKA – name: UNIVERSITE LIBRE DE BRUXELLES – name: LEO, OBERDAN |
| Score | 2.6017017 |
| Snippet | The present invention relates to the use of AMP-activated protein kinase (AMP-kinase) agonists or adenosine pro-drugs as immune enhancing compounds, as... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | AMP-KINASE AGONISTS OR ADENOSINE PRO-DRUGS AS IMMUNO-STIMULATING AGENTS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20041028&DB=EPODOC&locale=&CC=WO&NR=03037371A3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwjSt-BmGlsfhnRt11VsUppW9zaWroI-dMNV_PdN6uZ80aeEhByXg7vLJbnfAVxJWmgQkBzbk2KKNeAdvjMpwZLIF6pMpux2daJwxG6HmfkwoqMGvK1yYWqc0M8aHFFpVK70vart9Xx9ieXVfysX1_JVDc3uB2nPM1bRsan9peH1e37MPe4arqviNoMlGiGKWMTqOmQDNvUxWuPs-099nZUy_-1SBnuwFStqZbUPjaJswY67qrzWgu1o-eCtukvdWxxA4EQxVsG2I3zkBJyFIhWIJ0iJknFdPAPFCcdekgUCOQKFUZQxjkUaRtmjk4YsUKt8lopDuBz4qTvEiqPxz_bHz3zNPDmCZjkri2NA1J7msmNaUyInZi6pUjy70NGudWNS1ZxA-2867f8mT2H3G86wg2_sM2hW7x_FuXK9lbyoZfYF87KBDA |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaP4NROzt0Zhq5sPxIxtjClrl7VT3ggdM9GHQWTGf992gviiT23a9HK95O56be93AFcC5woEJEP2JJ8iBXiH7kxsIGGIFyxNpmi3VaJwRG4HqfkwwqMavK1yYSqc0M8KHFFqVCb1vazs9Xx9ieVVfysX1-JVDs3u-7zr6avo2FT-Uvd6XT-mHnV115Vxm04ShRBlWIbVdowN2LQUOq86Oj31VFbK_LdL6e_CViypFeUe1PKiCQ13VXmtCdvR8sFbdpe6t9iHwIliJINth_maE1ASMs40mmhSlISq4hlanFDkJWnANIdpYRSlhCLGwygdOjwkgVzlE84O4LLvc3eAJEfjn-2Pn-maeeMQ6sWsyI9Aw_Y0EzemNTXExMwElopn5yratTomls0xtP6m0_pv8gIaAx4Nx8OQPJ7Azje04Q3q2KdQL98_8jPphktxXsnvCyVQg_k |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=AMP-KINASE+AGONISTS+OR+ADENOSINE+PRO-DRUGS+AS+IMMUNO-STIMULATING+AGENTS&rft.inventor=BAUS%2C+ERIKA&rft.inventor=LEO%2C+OBERDAN&rft.date=2004-10-28&rft.externalDBID=A3&rft.externalDocID=WO03037371A3 |